hypomethylating agents in mds and aml
Published 4 years ago • 351 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
0:55
the role of rna modifications in mds and aml
-
1:50
hypomethylating agent based combinations in mds
-
1:56
are hypomethylating agents useful in preventing relapse in aml and mds?
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
3:21
mode of action of hypomethylating agents for mds
-
13:02
introduction to hematology |medical laboratory science
-
3:28
preclinical studies of tasquinimod in mds: in vitro and in vivo investigations
-
50:56
chip and ccus, precursors to mds
-
7:28
mbg453 with hypomethylating agents in aml and high-risk mds
-
1:12
hypomethylating agents for low risk mds
-
5:08
combining hypomethylating agents in aml
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
3:08
hypomethylating agents in aml
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:14
promising novel agents in aml: menin inhibitors
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
1:02
role of hypomethylating agents in the novel agent era
-
1:32
next-generation sequencing for low-risk mds
-
1:16
state of the art: mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data